Affymetrix Microarrays Uncover Genetic Mutations in Embryonic Stem Cells
News Sep 05, 2005
Affymetrix Inc. has announced that a research group led by scientists at Johns Hopkins School of Medicine and the NIH used Affymetrix GeneChip® microarrays to discover that eight of the stem cell lines approved for federally-funded research have mutated, raising concern about the use of the remaining 14 approved cell lines in future research or therapeutic applications.
The researchers used two GeneChip microarrays - the Human the Mapping 100K Set and Mitochondrial Resequencing Array 2.0 - to scan the stem cell genome at a level of detail never before possible.
They found previously undetectable mutations in stem cells that had been grown in the laboratory for dozens of generations.
The results of their study are published in an online issue of Nature Genetics.
The cell lines discovered as mutant in this study are part of the limited number of existing human embryonic stem cell lines (hESC) approved by President Bush for federally-funded research in August 2001.
At the time, scientists estimated that 60 genetically distinct stem cell lines existed, but only 22 are available for purchase in federally-supported research.
To find the embryonic stem cell mutations, the group used three different analysis methods - two of them microarrays - to compare the genomes of early generation and late generation cells.
The researchers looked at human nuclear DNA for mutations using the Mapping 100K Set; they used the Human Mitochondrial Resequencing Array 2.0 to look for mutations in mitochondrial DNA.
By combining two different whole-genome microarray experiments with a complementary technology that focused on a handful of individual genes, the stem cell group was able to explore the genome in many different ways that together proved far effective than any single approach.
3D Printer Developed That Can Create Complex Biological TissuesNews
A UCLA bioengineer has developed a technique that uses a specially adapted 3D printer to build therapeutic biomaterials from multiple materials. The advance could be a step toward on-demand printing of complex artificial tissues for use in transplants and other surgeries.READ MORE
Microfluidic Device Captures Extracellular Vesicles Shed by Brain TumorsNews
Because needle biopsies of brain tumors are invasive and difficult, bioengineers supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed micro-technologies that capture extracellular vesicles (EVs) released by the tumor.READ MORE
Making Drug Microparticles a Thousand Times FasterNews
Pharmaceuticals owe their effects mostly to their chemical composition, but the packaging of these drugs into specific physical formulations also need to be done to exact specifications. Engineers have now developed a microfluidic system where more than ten thousand devices run in parallel, all on a silicon-and-glass chip that can fit into a shirt pocket.READ MORE